Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$125.79 - $216.71 $3.69 Million - $6.35 Million
29,300 Added 38.4%
105,600 $22.3 Million
Q2 2024

Aug 14, 2024

BUY
$133.83 - $251.19 $1.9 Million - $3.57 Million
14,200 Added 22.87%
76,300 $10.2 Million
Q1 2024

May 15, 2024

BUY
$165.3 - $226.0 $6.07 Million - $8.29 Million
36,700 Added 144.49%
62,100 $13.3 Million
Q4 2023

Feb 14, 2024

BUY
$125.26 - $203.83 $3.06 Million - $4.97 Million
24,400 Added 2440.0%
25,400 $5.17 Million
Q2 2023

Aug 14, 2023

SELL
$226.52 - $324.64 $906,080 - $1.3 Million
-4,000 Reduced 80.0%
1,000 $324,000
Q4 2022

Feb 14, 2023

SELL
$164.02 - $259.76 $3.44 Million - $5.45 Million
-21,000 Reduced 80.77%
5,000 $1.26 Million
Q3 2022

Nov 14, 2022

BUY
$170.68 - $226.46 $3.41 Million - $4.53 Million
20,000 Added 333.33%
26,000 $4.61 Million

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.43B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.